Instituto de Diagnóstico S.A. (SNSE:INDISA)

Chile · Delayed Price · Currency is CLP

2,292.96

-0.84 (-0.04%)

At close: Nov 6, 2026

Market Cap	351.81B -8.3%
Revenue (ttm)	286.93B +13.5%
Net Income	12.68B +16.4%
EPS	84.54 +9.4%
Shares Out	153.43M
PE Ratio	27.12
Forward PE	n/a
Dividend	15.50 (0.68%)
Ex-Dividend Date	May 19, 2026

Volume	213
Open	n/a
Previous Close	2,293.80
Day's Range	n/a
52-Week Range	2,292.96 - 2,935.90
Beta	0.44
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About Instituto de Diagnóstico

Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising onl... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1961

Employees 3,108

Stock Exchange Santiago Stock Exchange

Ticker Symbol INDISA

Full Company Profile

Financial Performance

In 2025, Instituto de Diagnóstico's revenue was 272.31 billion, an increase of 13.90% compared to the previous year's 239.07 billion. Earnings were 15.66 billion, an increase of 115.23%.

Financial Statements